These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 16250054)

  • 1. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
    Wang H; Vohra BP; Zhang Y; Heuckeroth RO
    Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice.
    Wang H; Zhang Y; Heuckeroth RO
    Hepatology; 2007 Jun; 45(6):1527-37. PubMed ID: 17538930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
    Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
    Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA.
    Wang H; Zhang Y; Heuckeroth RO
    FEBS Lett; 2007 Jun; 581(16):3098-104. PubMed ID: 17561000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
    Li Z; Mizuno S; Nakamura T
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of time-related changes after experimental bile duct ligation.
    Georgiev P; Jochum W; Heinrich S; Jang JH; Nocito A; Dahm F; Clavien PA
    Br J Surg; 2008 May; 95(5):646-56. PubMed ID: 18196571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling in whole liver of bile duct ligated rats: VEGF-A expression is up-regulated in hepatocytes adjacent to the portal tracts.
    Tanaka A; Tsuneyama K; Mikami M; Uegaki S; Aiso M; Takikawa H
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1993-2000. PubMed ID: 17914982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis.
    Bergheim I; Guo L; Davis MA; Duveau I; Arteel GE
    J Pharmacol Exp Ther; 2006 Feb; 316(2):592-600. PubMed ID: 16221737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.
    Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ
    Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor-1 is an immediate early response gene in regenerating rat liver.
    Thornton AJ; Bruzdzinski CJ; Raper SE; Gelehrter TD
    Cancer Res; 1994 Mar; 54(5):1337-43. PubMed ID: 8118825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis.
    Shimizu M; Hara A; Okuno M; Matsuno H; Okada K; Ueshima S; Matsuo O; Niwa M; Akita K; Yamada Y; Yoshimi N; Uematsu T; Kojima S; Friedman SL; Moriwaki H; Mori H
    Hepatology; 2001 Mar; 33(3):569-76. PubMed ID: 11230736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous urokinase lacks antifibrotic activity during progressive renal injury.
    Yamaguchi I; Lopez-Guisa JM; Cai X; Collins SJ; Okamura DM; Eddy AA
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F12-9. PubMed ID: 17356128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kupffer cells abrogate cholestatic liver injury in mice.
    Gehring S; Dickson EM; San Martin ME; van Rooijen N; Papa EF; Harty MW; Tracy TF; Gregory SH
    Gastroenterology; 2006 Mar; 130(3):810-22. PubMed ID: 16530521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.
    Liu Z; Sakamoto T; Ezure T; Yokomuro S; Murase N; Michalopoulos G; Demetris AJ
    Hepatology; 1998 Nov; 28(5):1260-8. PubMed ID: 9794910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
    Tamaki N; Hatano E; Taura K; Tada M; Kodama Y; Nitta T; Iwaisako K; Seo S; Nakajima A; Ikai I; Uemoto S
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
    Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of fibrinolytic genes and proteins in the development of allograft vascular disease.
    Benza RL; Passineau MJ; Anderson PG; Barchue JP; George JF
    J Heart Lung Transplant; 2011 Aug; 30(8):935-44. PubMed ID: 21652221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of hepatic type 1 plasminogen activator inhibitor (PAI-1) during murine hemorrhagic shock.
    Lagoa CE; Vodovotz Y; Stolz DB; Lhuillier F; McCloskey C; Gallo D; Yang R; Ustinova E; Fink MP; Billiar TR; Mars WM
    Hepatology; 2005 Aug; 42(2):390-9. PubMed ID: 16025510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of plasminogen activator inhibitor-1 and -2 in dorsal root ganglion neurons after peripheral nerve injury.
    Yamanaka H; Obata K; Fukuoka T; Dai Y; Kobayashi K; Tokunaga A; Noguchi K
    Neuroscience; 2005; 132(1):183-91. PubMed ID: 15780477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.